Baricitinib protects ICIs-related myocarditis by targeting JAK1/STAT3 to regulate Macrophage polarization
Author:
Wang XuejunORCID, Chen Jiahui, Shen Yihui, Zhang Hui, Xu Yuchen, Zhang Jian, Cheng Leilei
Reference37 articles.
1. Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis;Puzanov;J Immunother Cancer.,2021 2. Johnson D B, Balko J M, Compton M L, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander M R, Bloomer T L, Becker J R, Slosky D A, Phillips E J, Pilkinton M A, Craig-Owens L, Kola N, Plautz G, Reshef D S, Deutsch J S, Deering R P, Olenchock B A, Lichtman A H, Roden D M, Seidman C E, Koralnik I J, Seidman J G, Hoffman R D, Taube J M, Diaz L A, Jr., Anders R A, Sosman J A, Moslehi J J. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med, 2016; 375(18): 1749-1755. 3. Immune checkpoint inhibitors mediated lymphocytic and giant cell myocarditis: uncovering etiological mechanisms;Rikhi;Front Cardiovasc Med.,2021 4. Metabolic coordination of physiological and pathological cardiac remodeling;Gibb;Circ Res.,2018 5. Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies;Steffens;Eur Heart J.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|